These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Effect of OKY-046, a thromboxane synthetase inhibitor, on renal thromboxane synthesis in spontaneously hypertensive rat]. Nakayama D; Ikeda T Nihon Jinzo Gakkai Shi; 1988 Jan; 30(1):79-84. PubMed ID: 3386014 [No Abstract] [Full Text] [Related]
11. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Purkerson ML; Joist JH; Yates J; Valdes A; Morrison A; Klahr S Proc Natl Acad Sci U S A; 1985 Jan; 82(1):193-7. PubMed ID: 3855542 [TBL] [Abstract][Full Text] [Related]
12. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord]. Morimoto K; Ikata T; Tounai T Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats. Purkerson ML; Martin KJ; Yates J; Kissane JM; Klahr S Hypertension; 1986 Dec; 8(12):1113-20. PubMed ID: 3793195 [TBL] [Abstract][Full Text] [Related]
14. [Anti-allergic effects of (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046), a specific thromboxane (TX) A2 synthetase inhibitor: effect of OKY-046 on II-IV type allergic reactions]. Kikuchi S; Takehana Y; Hamano S; Ichikawa K; Komatsu H; Okegawa T; Ikeda S Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):131-7. PubMed ID: 2141317 [TBL] [Abstract][Full Text] [Related]
15. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts. Coffman TM; Ruiz P; Sanfilippo F; Klotman PE Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752 [TBL] [Abstract][Full Text] [Related]
16. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy. Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S Nephron; 1990; 56(3):297-305. PubMed ID: 2077412 [TBL] [Abstract][Full Text] [Related]
17. OKY-1581: a selective inhibitor of thromboxane synthesis in vivo and in vitro. Smith JB; Jubiz W Prostaglandins; 1981 Sep; 22(3):353-63. PubMed ID: 7302264 [TBL] [Abstract][Full Text] [Related]
18. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death. Edmonds LC; Lefer AM Life Sci; 1984 Oct; 35(17):1763-8. PubMed ID: 6434893 [TBL] [Abstract][Full Text] [Related]
19. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. Casey LC; Fletcher JR; Zmudka MI; Ramwell PW J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528 [TBL] [Abstract][Full Text] [Related]
20. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs. Ishihara Y; Uchida Y; Kitamura S Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]